Why Edgewell Personal Care’s updated outlook matters now

Edgewell Personal Care (EPC) has lowered its fiscal 2026 earnings guidance and reported weaker third quarter profit metrics, with net income and earnings per share down sharply compared with the same period last year.

At the same time, the company kept shareholder return programs active. It affirmed a quarterly dividend, detailed past buyback activity, and outlined remaining repurchase capacity. This provides additional context for assessing how management is balancing growth investments and capital returns.

The earnings reset and dividend update have followed a sharp move in Edgewell Personal Care’s share price. The 90 day share price return is 32.33% and the year to date share price return is 66.79%, while the 1 year total shareholder return of 30.96% contrasts with weaker 3 and 5 year total shareholder returns.

If this kind of shift in expectations has you reassessing your watchlist, it can be useful to look across other opportunities with different drivers. One place to start is a focused Simply Wall St screener that highlights 20 top founder-led companies

After a sharp move in Edgewell Personal Care’s share price and a wide spread between its current price and various fair value estimates, the real tension is where fair value sits. Is the market now ahead of itself or still skeptical?

Most Popular Narrative: 16.6% Undervalued

Compared with Edgewell Personal Care’s last close at $28.12, the most widely followed narrative pegs fair value closer to the mid $30s, using a detailed earnings and cash flow path to get there.

The bullish analysts are assuming Edgewell Personal Care's revenue will decrease by 3.2% annually over the next 3 years.

The bullish analysts assume that profit margins will increase from -0.5% today to 32.3% in 3 years time.

Want to see how a shrinking top line can still support a higher fair value for Edgewell Personal Care? The narrative leans on a sharp swing in profitability and a future earnings multiple that looks very different from today. Curious which specific margin and earnings paths underpin that conclusion and how buybacks factor into the share count story?

Result: Fair Value of $33.73 (UNDERVALUED)

However, this upbeat Edgewell Personal Care narrative can be challenged if North American weakness persists, or if rising competition and regulatory pressures weigh on pricing power.

Next Steps

The mixed tone around Edgewell Personal Care, with both risks and rewards highlighted, makes this a useful moment to review the numbers yourself and form your own stance quickly. To see the balance of concerns and potential upsides that other investors are focused on, start with these 3 key rewards and 2 important warning signs

Looking for more investment ideas beyond Edgewell Personal Care?

If Edgewell Personal Care has you thinking differently about valuation and risk, this is the moment to widen your search before the next move passes you by.

• Target stability first by checking companies that combine resilient financials and low risk scores through the 78 resilient stocks with low risk scores.
• Spot potential value ahead of the crowd by scanning companies with strong fundamentals that still look attractively priced using the screener containing 19 high quality undiscovered gems.
• Focus on quality and balance sheet strength by filtering for stocks with solid fundamentals and cleaner debt profiles through the solid balance sheet and fundamentals stocks screener (49 results).

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.